However, we found that the prognostic value of CD8+CD28+ T cells in SCCs and CD8+CD28− T cells in ADs did not reach statistical significance, which may have arisen from the differences in tumor immunity, gene expression, and methylation between ADs and SCCs [ 6 , 17 – 20 ].
← all excerpts
Prognostic significance of peripheral CD8+CD28+ and CD8+CD28- T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy.
1
—
—